Keywords: cangene, hepagam, gets, approval, canadian, biotechnology, group

Cangene's HepaGam gets US approval

Article | 06 February 2006

Print This

Canadian biotechnology group Cangene says that the US Food and Drug Administration has approved its HepaGam B for treatment following ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in